Peripheral Arterial Disease News and Research

RSS

Study shows safety, efficacy of stem cells in treating angiitis-induced critical limb ischemia

A long-term study of patients who received stem cells to treat angiitis-induced critical limb ischemia (AICLI) shows the cells to be both safe and effective.

2 May 2018

Machine learning can help accurately predict clinical outcomes in patients with heart problems

Several studies being presented at the American College of Cardiology's 67th Annual Scientific Session demonstrate how the computer science technique known as machine learning can be used to accurately predict clinical outcomes in patients with known or potential heart problems.

1 Mar 2018

Statin use linked to reduced risk of S aureus bloodstream infection

Users of statins, widely prescribed for prevention of cardiac disease, have a 27% lower risk of contracting a Staphylococcus aureus (S aureus) bloodstream infection outside of a hospital, according to a new study in Mayo Clinic Proceedings.

3 Oct 2017

ESC recommendations on management of patients with peripheral arterial diseases published

European Society of Cardiology Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular Surgery (ESVS), are published online today in European Heart Journal, European Journal of Vascular and Endovascular Surgery, and the ESC website.

26 Aug 2017

Study identifies heart failure and stroke as lethal combination

Heart failure and stroke has been identified as a lethal combination in research presented today at EuroHeartCare 2017. Heart failure patients with previous stroke had greater risks of depression, hospitalization and death than those without a history of stroke.

22 May 2017

New article finds rising trend in hospitalization for hypertensive emergency with reduction in mortality

A new article published in the American Journal of Hypertension finds a rising trend in hospitalization for hypertensive emergency with reduction in hospital mortality during the last decade. The presence of acute cardiorespiratory failure, chest pain, stroke, acute chest pain, and aortic dissection were most predictive of higher hospital mortality among other complications.

21 Apr 2017

Penn State researchers receive NIH grant to improve lives of people with peripheral arterial disease

A $9.7 million National Institutes of Health project grant to Penn State College of Medicine aims to improve the lives of millions of people living with peripheral arterial disease.

16 Mar 2017

‘Heart disease’ related to hardening of arteries could affect feet, kidneys and the brain

In February, American Heart Month raises awareness about heart disease. But "heart disease" is a catch-all term that refers to numerous problems, many of which are related to hardening of the arteries.

9 Feb 2017

Study explores incidence of heart failure following myocardial infarction

One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25 000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr Johannes Gho, a cardiology resident at the University Medical Center Utrecht, in Utrecht, the Netherlands.

24 May 2016

Vascular events in CML may not be linked to TKI therapy

The increased risk of vascular events observed among elderly patients with chronic myeloid leukaemia, compared with patients without cancer, may not be driven by tyrosine kinase inhibitor therapy, US researchers suggest.

17 Mar 2016

UC San Diego physicians develop potential new therapy for critical limb ischemia

Bioengineers and physicians at the University of California, San Diego have developed a potential new therapy for critical limb ischemia, a condition that causes extremely poor circulation in the limbs and leads to an estimated 230,000 amputations every year in North America and Europe alone to prevent the spread of infection and tissue death.

9 Mar 2016

Unique cardiovascular disease risk calculator for black adults may not be necessary: Study

Although cardiovascular disease risk prediction models are developed with predominantly white populations, application of models to a large black population finds that they work well in black individuals and are not easily improved on, suggesting that a unique risk calculator for black adults may not be necessary, according to a study published online by JAMA Cardiology.

25 Feb 2016

University of Louisville researcher reveals potentially harmful effects of e-cigarettes

While e-cigarette use is increasing worldwide, little is known about the health effects e-cigarettes pose for users. A University of Louisville researcher is working to change that status.

12 Feb 2016

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen today announced that the Japanese Ministry of Health, Labour and Welfare has approved the cholesterol-lowering medication Repatha (evolocumab) Injection, the first proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to be approved in Japan.

22 Jan 2016

New research aims to help people suffering from poor blood circulation, reduce aching pains

The University of Salford is looking for volunteers to take part in a new research study that aims to help people who suffer from poor blood circulation to walk without pain.

10 Dec 2015

Review of haemodynamics in stent development shows spiral flow may be key to improving peripheral arterial stent performance

Vascular Flow Technologies, the medical device company using proprietary Spiral Laminar Flow (SLF™) technology to replicate natural blood flow for enhanced patient outcomes, today announces that 'Haemodynamics and Flow Modification Stents for Peripheral Arterial Disease: A Review’, co-authored by VFT’s non-executive Medical Director Graeme Houston, has been published in the Annals of Biomedical Engineering. The paper reviews the importance of haemodynamics in stent development as a method of improving patency and longevity of the stent.

4 Nov 2015

Semler Scientific's revenue up 74% in third quarter 2015

Semler Scientific, Inc., a company that provides diagnostic and testing services to healthcare insurers and physician groups, today reported financial results for the third quarter ended September 30, 2015.

30 Oct 2015

CV risk assessment essential for CML TKI trial design

The risk and impact of cardiovascular adverse events in long-term users of tyrosine kinase inhibitors for chronic myeloid leukaemia is highlighted in a review published in the Journal of Clinical Oncology.

22 Oct 2015

LEADERS FREE clinical trial demonstrates superior safety, efficacy for BioFreedom compared with bare-metal stent

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, announced today that the LEADERS FREE clinical trial demonstrated superior safety and efficacy for BioFreedom compared with a bare-metal stent (BMS).

15 Oct 2015

Vascular side effects prevent first-line ponatinib use in chronic phase CML

Ponatinib is highly active when given to patients within 6 months of developing chronic phase chronic myeloid leukaemia, phase II results show, but its toxicity profile is unacceptable for first-line treatment.

7 Aug 2015